Am J Perinatol 2014; 31(02): 099-104
DOI: 10.1055/s-0033-1338172
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Prediction of Recurrent Preeclampsia Using First-Trimester Uterine Artery Doppler

Suzanne Demers
1   Departments of Obstetrics and Gynecology, Faculty of Medicine, Université Laval, Quebec City, Canada
,
Emmanuel Bujold
1   Departments of Obstetrics and Gynecology, Faculty of Medicine, Université Laval, Quebec City, Canada
,
Edgar Arenas
2   Harris Birthright Research Centre of Fetal Medicine, King's College Hospital, London, United Kingdom
,
Ariel Castro
2   Harris Birthright Research Centre of Fetal Medicine, King's College Hospital, London, United Kingdom
,
Kypros H. Nicolaides
2   Harris Birthright Research Centre of Fetal Medicine, King's College Hospital, London, United Kingdom
› Author Affiliations
Further Information

Publication History

04 December 2012

10 January 2013

Publication Date:
18 March 2013 (online)

Abstract

Objective To evaluate the role of first-trimester uterine artery Doppler in the prediction of recurrent preeclampsia (PE).

Methods Uterine artery pulsatility index (UtPI) was measured at 11 to 13 weeks' gestation in 1,810 women with singleton pregnancies who had developed PE in a previous pregnancy. They were categorized into three subgroups according to UtPI multiple of median (MoM): < 1.0, 1.0 to 1.49, and ≥ 1.50 MoM. The rate of early onset PE (< 34 weeks), intermediate PE (34 to 36 weeks), late PE (≥ 37 weeks), perinatal death, and small-for-gestational-age outcome (SGA; below the 5th percentile) were compared between each subgroup.

Results The median mean UtPI decreased with advancing crown-rump length (CRL) from 1.77 at CRL of 45 to 54 mm to 1.52 at CRL of 75 to 84 mm. UtPI < 1.0 MoM was associated with a low-risk of early PE (0.2%), intermediate PE (0.3%), perinatal death (0.3%), and SGA (3.3%). The risk for these complications increases with UtPI of 1.0 to 1.4 MoM or ≥ 1.5 MoM (early PE 2.8 and 14.3%, respectively, p < 0.001; intermediate PE 2.1 and 5.4%, p < 0.001; perinatal death 1.3 and 6.8%, p < 0.001; and SGA 8.0 and 20.9%, p < 0.001).

Conclusion In women with previous PE, first-trimester UtPI discriminates women at high and low risk for recurrence of PE and adverse pregnancy outcomes.

 
  • References

  • 1 Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-137
  • 2 Ogge G, Chaiworapongsa T, Romero R , et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 2011; 39: 641-652
  • 3 Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC, Giguere Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can 2009; 31: 818-826
  • 4 Bujold E, Roberge S, Lacasse Y , et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116: 402-414
  • 5 Roberge S, Giguere Y, Villa P , et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol 2012; 29: 551-556
  • 6 Roberge S, Villa P, Nicolaides K , et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012; 31: 141-146
  • 7 National Health Service, National Institute for Health and Clinical Excellence. National Collaborating Centre for Women's and Children's Health. In: Hypertension in Pregnancy, The Management of Hypertensive Disorders during Pregnancy. NICE Clinical Guideline 107; January 2011
  • 8 Magee LA, Helewa M, Moutquin JM, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008; 30: S1-S48
  • 9 Lowe SA, Brown MA, Dekker GA , et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 2009; 49: 242-246
  • 10 Melamed N, Hadar E, Peled Y, Hod M, Wiznitzer A, Yogev Y. Risk for recurrence of preeclampsia and outcome of subsequent pregnancy in women with preeclampsia in their first pregnancy. J Matern Fetal Neonatal Med 2012; 25: 2248-2251
  • 11 Lykke JA, Paidas MJ, Langhoff-Roos J. Recurring complications in second pregnancy. Obstet Gynecol 2009; 113: 1217-1224
  • 12 Cnossen JS, Morris RK, ter Riet G , et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008; 178: 701-711
  • 13 Espinoza J, Romero R, Nien JK , et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007; 196: 321-313
  • 14 Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007; 30: 742-749
  • 15 Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2012;
  • 16 Lefebvre J, Demers S, Bujold E , et al. Comparison of two different sites of measurement for transabdominal uterine artery Doppler velocimetry at 11–13 weeks. Ultrasound Obstet Gynecol 2012; 40: 288-292
  • 17 Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IX-XIV
  • 18 Poon LC, Volpe N, Muto B, Syngelaki A, Nicolaides KH. Birthweight with gestation and maternal characteristics in live births and stillbirths. Fetal Diagn Ther 2012;
  • 19 Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH. Combined screening for preeclampsia and small for gestational age at 11–13 weeks. Fetal Diagn Ther 2012;
  • 20 Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003; 189: 1173-1177
  • 21 Yu CK, Khouri O, Onwudiwe N, Spiliopoulos Y, Nicolaides KH. Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age. Ultrasound Obstet Gynecol 2008; 31: 310-313
  • 22 Sebire NJ, Goldin RD, Regan L. Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol 2005; 25: 117-118
  • 23 Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease?. BJOG 2004; 111: 298-302
  • 24 Prefumo F, Fratelli N, Ganapathy R, Bhide A, Frusca T, Thilaganathan B. First trimester uterine artery Doppler in women with previous pre-eclampsia. Acta Obstet Gynecol Scand 2008; 87: 1271-1275
  • 25 Vainio M, Kujansuu E, Koivisto AM, Maenpaa J. Bilateral notching of uterine arteries at 12–14 weeks of gestation for prediction of hypertensive disorders of pregnancy. Acta Obstet Gynecol Scand 2005; 84: 1062-1067
  • 26 Llurba E, Carreras E, Gratacos E , et al. Maternal history and uterine artery Doppler in the assessment of risk for development of early- and late-onset preeclampsia and intrauterine growth restriction. Obstet Gynecol Int 2009; 2009: 275613
  • 27 Staboulidou I, Galindo A, Maiz N, Karagiannis G, Nicolaides KH. First-trimester uterine artery Doppler and serum pregnancy-associated plasma protein-a in preeclampsia and chromosomal defects. Fetal Diagn Ther 2009; 25: 336-339
  • 28 Herraiz I, Lopez-Jimenez EA, Garcia-Burguillo A , et al. Role of uterine artery Doppler in interpreting low PAPP-A values in first-trimester screening for Down syndrome in pregnancies at high risk of impaired placentation. Ultrasound Obstet Gynecol 2009; 33: 518-523